)
Edge17 Oct 2025
A Castle in the Sky: The Story of Oracle
Oracle's journey from database innovator to disciplined enterprise backbone, now shaping the AI buildout with a standardized cloud infrastructure.
Artiva Biotherapeutics (ARTV) investor relations material
Artiva Biotherapeutics Cantor Global Healthcare Conference 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Cantor Global Healthcare Conference 2025 summary3 Sep, 2025
Program overview and technology
Focused on non-genetically modified NK cell therapies, combined with monoclonal antibodies for enhanced ADCC and B cell killing.
NK cells sourced from umbilical cord units, enabling large-scale, long-shelf-life, infusion-ready products.
Therapy is designed for rapid IV administration and offers a safety profile superior to T cell-based modalities.
Clinical work has shifted from oncology to autoimmunity, with multiple ongoing trials in various indications.
Differentiation and competitive landscape
Emphasizes high efficacy and safety, aiming for compatibility with community-based administration.
Seeks to outperform monoclonal antibodies and align with or exceed the best standard of care in each indication.
Prior oncology trials demonstrated high complete response rates and durability, supporting confidence in autoimmunity applications.
Flexibility in dosing allows for repeat treatments, distinguishing from more intensive CAR T regimens.
Regimen components and safety considerations
Regimen includes cyclophosphamide, fludarabine, rituximab, and allo NK cells, with low doses of CyFlu to minimize risk.
CyFlu is used to prevent immune rejection and enable NK cell persistence, with transient effects on immune cells.
Safety profile is being closely monitored, with optional prophylactic antibiotics and antivirals to address infection risk.
Target product profile aims for outpatient and community setting compatibility, minimizing hospitalization and severe adverse events.
Why is Arteva's FluCy regimen community-compatible?
AlloNK's unique profile vs. other B-cell depleters
What data will define Arteva's lead indication?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Artiva Biotherapeutics earnings date
Q3 20256 Nov, 2025
Next Artiva Biotherapeutics earnings date
Q3 20256 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research17 Oct 2025
Beneath the Surface: A Conversation with Epiroc CEO Helena Hedblom
Legacy, innovation, and leading one of Sweden's most influential industrial companies into a new era.
)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Frequently asked questions
Artiva Biotherapeutics Inc. is a biotechnology company focused on developing off-the-shelf, allogeneic natural killer (NK) cell therapies for cancer treatment. The company's therapies utilize NK cell technology combined with advanced genetic engineering and proprietary manufacturing processes to enhance the effectiveness of NK cells in targeting cancer cells. Artiva’s therapeutic platforms are designed to address various cancer types, with an emphasis on scalability and accessibility for patients. Its development pipeline covers multiple forms of immunotherapies aimed at both solid tumors and hematologic malignancies. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage